Atherosclerosis: nexus of vascular dynamics and cellular cross talks

Divya Dasagrandhi1, Anusuyadevi Muthuswamy2, Jayachandran Kesavan Swaminathan3

  • 1Drug Discovery and Molecular Cardiology Laboratory, Department of Bioinformatics, Bharathidasan University, Tiruchirappalli, 620024, India.

Insights

Atherosclerosis, the root of cardiovascular diseases (CVDs), involves plaque buildup and inflammation. Understanding its triggers and progression is key to developing early diagnosis and effective treatments for CVDs.

Area of Science:

  • Cardiovascular Science
  • Pathophysiology
  • Medical Research

Background:

  • Cardiovascular diseases (CVDs) are the leading global cause of death.
  • Atherosclerosis, characterized by vascular intima lipid deposition, plaque formation, and inflammation, underlies most CVDs.
  • Plaque development is a lengthy process, with aging increasing vulnerability and coronary artery localization leading to myocardial infarction.

Purpose of the Study:

  • To provide a comprehensive understanding of atherosclerosis pathophysiology.
  • To identify key determinants and triggering factors of atherosclerosis.
  • To explore potential therapeutic targets for early diagnosis and treatment of CVDs.

Main Methods:

  • Review of existing literature on atherosclerosis.
  • Analysis of crucial determinants including plaque location and hemodynamic factors.
  • Examination of the roles of oxidized low-density lipoproteins, endothelial cells, vascular smooth muscle cells, and immune cells.

Main Results:

  • Atherosclerosis is triggered by biomechanical forces, hyperlipidemia, and chronic inflammation.
  • Key factors influencing plaque development include location, hemodynamics, and LDL oxidation.
  • Cellular players like endothelial cells, vascular smooth muscle cells, and immune cells are integral to the disease process.

Conclusions:

  • A thorough understanding of atherosclerosis pathophysiology is essential for clinical advancements.
  • Identifying specific determinants and cellular mechanisms can guide the development of novel therapeutic strategies.
  • Targeting key factors in atherosclerosis progression offers potential for improved early diagnosis and treatment of cardiovascular diseases.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
163
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
78
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
85
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Inflammation01:38

Inflammation

Overview
56.1K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
95